Chinese expert consensus on the safety of multiple medications for patients with type 2 diabetes combined with chronic kidney disease

Title: Chinese expert consensus on the safety of multiple medications for patients with type 2 diabetes combined with chronic kidney disease
Edition: Original
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users: Clinicians, clinical pharmacists, nursing staff, and other potential users of the guidelines
Evidence classification method: GRADE
Development unit: 上海交通大学医学院附属新华医院
Registration time: 2021-08-10
Registration number: IPGRP-2021CN261
Purpose of the guideline: With the intensification of aging, the number of elderly patients with T2DM combined with CKD is increasing. Such patients have particularity in terms of multiple drug management methods and target formulation, rational drug use principles, etc. It is urgent to standardize and refine the management of multiple drug management in elderly patients with T2DM combined with CKD to improve the clinical prognosis of elderly patients.